Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke "Citicoline 007"

Completed

Phase 3 Results

Summary of Purpose

To evaluate the safety and effectiveness of 500mg citicoline compared to placebo in patients who are examined within 24 hours of stroke onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Interneuron Pharmaceuticals, Lexington, MA

Trial Design

Randomized, double-blind, efficacy trial involving 394 patients at 31 U.S. centers.

Contacts

  • Dr. Wayne M. Clark, Oregon Stroke Center UHS 44, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR 97201

    clarkw@ohsu.edu